United States Chemical Indicators Market Size, Share, and COVID-19 Impact Analysis, By Product (Strips, Indicators Tapes, Cards, and Others), By End-Use (Hospitals and Clinics, Biopharma/Biotech Companies, Ambulatory Surgery Centers, Research and Academic Institutes, and Others), and United States Chemical Indicators Market Insights, Industry Trend, Forecasts to 2035

United States Chemical Indicators Market Insights Forecasts to 2035

• The United States Chemical Indicators Market Size Was Estimated at USD 149.6 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 4.75% from 2025 to 2035
• The United States Chemical Indicators Market Size is Expected to Reach USD 249.24 Million by 2035

According to a research report published by Spherical Insights & Consulting, the United States chemical indicators market size is anticipated to reach USD 249.24 Million by 2035, growing at a CAGR of 4.75% from 2025 to 2035. The United States chemical indicators market is growing due to stringent sterilization regulations and compliance requirements across healthcare facilities, increasing demand for infection control in healthcare facilities, and growth in pharmaceutical manufacturing.

Market Overview

The United States chemical indicators market is the industry producing and supplying chemical indicators such as strips, tapes, and cards used to monitor sterilization, chemical reactions, and safety compliance across healthcare, pharmaceuticals, and industrial sectors. The United States chemical indicators market is used for monitoring sterilization processes, ensuring infection control in healthcare, validating pharmaceutical manufacturing, supporting laboratory testing, maintaining food safety standards, and enabling industrial process control to meet regulatory and quality compliance requirements. The market is driven by increasing demand for infection control in healthcare facilities, stringent sterilization and safety regulations, growth in pharmaceutical manufacturing, rising surgical procedures, and expanding laboratory and food safety testing activities.

Key opportunities in the United States chemical indicators market include advancements in sterilization technologies, growing demand for infection prevention, expansion of pharmaceutical and biotechnology industries, increasing outpatient and surgical procedures, and rising regulatory focus on quality assurance and compliance. In February 2026, the U.S. FDA’s QMSR, aligned with ISO 13485:2016, strengthened risk management and sterilization validation requirements. This increases demand for reliable chemical indicators in medical device manufacturing, supporting compliance, quality assurance, and growth in the United States chemical indicators market.

Report Coverage

This research report categorizes the market for the United States chemical indicators market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States chemical indicators market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States chemical indicators market.

Driving Factors

The United States chemical indicators market is driven by the rising number of surgical procedures and the growing number of outpatient and dental centers, increasing the need for routine sterilization monitoring. Heightened focus on infection prevention, patient safety, and regulatory compliance has strengthened sterilization validation practices across healthcare facilities. Additionally, the adoption of advanced sterilization technologies and adherence to standards such as ISO 11140-1 are boosting demand for specialized and high-performance chemical indicator products.

Restraining Factors

The United States chemical indicators market is mostly constrained by the high competition from biological indicators and digital monitoring systems, which may limit product adoption. Additionally, pricing pressures, strict regulatory requirements, and budget constraints in healthcare facilities can restrict purchasing decisions.

Market Segmentation

The United States chemical indicators market share is classified into product and end-use.

The strips segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 
The United States chemical indicators market is segmented by product into strips, indicator tapes, cards, and others. Among these, the strips segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due widespread use of chemical indicator strips for routine sterilization monitoring in healthcare facilities. They provide clear visual results, are easy to place inside instrument packs, and offer a cost-effective solution. Their compatibility with multiple sterilization methods, especially steam and ethylene oxide, drives strong adoption across hospitals, clinics, and central sterile processing departments.

The hospitals and clinics segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. 
The United States chemical indicators market is segmented by end-use into hospitals and clinics, biopharma/biotech companies, ambulatory surgery centers, research and academic institutes, and others. Among these, the hospitals and clinics segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. This is due to the high number of surgical procedures and routine instrument reprocessing in healthcare settings, which necessitate continuous sterilization monitoring to meet infection control and patient safety standards. The existence of central sterile services departments (CSSDs) in large hospitals and stringent regulatory oversight further support consistent demand for chemical indicators.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States chemical indicators market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Hu-Friedy Mfg. Co.
• True Indicating
• Tuttnauer
• Andersen Sterilizers
• Mesa Laboratories, Inc.
• Propper Manufacturing Co.
• STERIS
• ASP
• Solventum
• Getinge
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• June 2025: Solventum launched the Attest Super Rapid VH2O2 Clear Challenge Pack, an FDA-cleared all-in-one biological and chemical indicator pack designed to improve sterilization monitoring accuracy, convenience, and patient safety in healthcare facilities.

• January 2025: True Indicating, LLC introduced its FDA-cleared CSPN-15 Type 5 Integrating Indicator for Steam, offering a high-performance solution that enhances sterilization monitoring and supports better compliance and patient safety in healthcare environments.

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States chemical indicators market based on the below-mentioned segments:

United States Chemical Indicators Market, By Product

• Strips
• Indicators Tapes
• Cards
• Others

United States Chemical Indicators Market, By End-Use

• Hospitals and Clinics
• Biopharma/Biotech Companies
• Ambulatory Surgery Centers
• Research and Academic Institutes
• Others